Seminars in Pediatric Surgery
Volume 15, Issue 3 , Pages 199-207 , August 2006

Pediatric lung transplantation

  • Charles B. Huddleston, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests and correspondence: Charles B. Huddleston, MD, #1 Children’s Place, Suite 5S 50, St. Louis, MO 63110.

References 

  1. Cooper JD , Ginsberg RJ , Goldberg M  the Toronto Lung Transplant Group . Unilateral transplantation for pulmonary fibrosis . N Engl J Med . 1986;314:1140–1145
  2. Boucek MM , Edwards LB , Keck BM , et al.   Registry of the International Society for Heart and Lung Transplantation (eighth official pediatric report, 2005) . J Heart Lung Transplant . 2005;24:968–982
  3. Cystic Fibrosis Foundation, Patient Registry Annual Report, 2-12 . 2004;
  4. Kerem E , et al.   Prediction of mortality in patients with cystic fibrosis . N Engl J Med . 1992;326:1187–1191
  5. Mayer-Hamblett N , et al.   Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality . Am J Respir Crit Care Med . 2002;166:1550–1555
  6. Moorcroft AJ , Dodd ME , Webb AK . Exercise testing and prognosis in adult cystic fibrosis . Thorax . 1997;523:291–293
  7. Tantisira KG , Systrom DM , Ginns LC . An elevated breathing reserve index at the lactate threshold is a predictor of mortality in patients with cystic fibrosis awaiting lung transplantation . Am J Respir Crit Care Med . 2002;165:1629–1633
  8. Aurora P , et al.   A model for predicting life expectancy of children with cystic fibrosis . Eur Respir J . 2000;16:1056–1060
  9. Vizza CD , et al.   Outcome of patients with cystic fibrosis awaiting lung transplantation . Am J Respir Crit Care Med . 2000;162:819–825
  10. Stanchina ML , et al.   Association of lung perfusion disparity and mortality in patients with cystic fibrosis awaiting lung transplantation . J Heart Lung Transplant . 2002;21:217–225
  11. Sharma R , et al.   Wasting as an independent predictor of mortality in patients with cystic fibrosis . Thorax . 2001;56:746–750
  12. Rosenbluth DB , Wilson K , Ferkol T , et al.   Lung function decline in cystic fibrosis patients and timing for lung transplantation . Chest . 2004;126:412–419
  13. Rosenzweig EB , Barst R . Idiopathic pulmonary arterial hypertension in children . Curr Opin Ped . 2005;17:372–380
  14. Barst RJ , Maislin G , Fishman AP . Vasodilator therapy for primary pulmonary hypertension in children . Circulation . 1999;99:1197–1208
  15. Shapiro SM , Oudiz RJ , Cao T , et al.   Primary pulmonary hypertension (improved long-term effects and survival with continuous intravenous epoprostenol infusion) . J Am Coll Cardiol . 1997;30:343–349
  16. Okano Y , Yoshioka T , Shimouchi A , et al.   Orally active prostacyclin analogue in primary pulmonary . Lancet . 1997;349:1365
  17. Barst RJ , McGoon M , McLaughlin V , et al.  Beraprost Study Group   Beraprost therapy for pulmonary arterial hypertension . J Am Coll Cardiol . 2003;41:2119–2125
  18. Olschewski H , Simonneau G , Galie N , et al.  Aerosolized Iloprost Randomized Study Group   Inhaled iloprost for severe pulmonary hypertension . N Engl J Med . 2002;347:322–329
  19. Barst RJ , Horn EM , Widlitz AC , et al.   Efficacy of long-term subcutaneous infusion of UT-15 in primary pulmonary hypertension . Eur Heart J . 2000;21:315
  20. Rosenzweig EB , Ivy DD , Widlitz A , Doran A , Claussen LR , Yung D , et al.   Effects of long-term bosentan in children with pulmonary arterial hypertension . J Am Coll Card . 2005;46:697–704
  21. Sastry BK , Narasimhan C , Reddy NK , Raju BS . Clinical efficacy of sildenafil in primary pulmonary hypertension . J Am Coll Cardiol . 2004;43:1149–1153
  22. Sandoval J , Gaspar J , Pulido T , et al.   Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension. A therapeutic alternative for patients nonresponsive to vasodilator treatment . J Am Coll Cardiol . 1998;32:297–304
  23. D’Alonzo GE , Barst RJ , Ayres SM , et al.   Survival in patients with primary pulmonary hypertension. Results from a national prospective registry . Ann Intern Med . 1991;115:343–349
  24. Clabby ML , Canter CE , Moller JH , Bridges ND . Hemodynamic data and survival in children with pulmonary hypertension . J Am Coll Cardiol . 1997;30:554–560
  25. Hopkins WE , Ochoa LL , Richardson GW , Trulock EP . Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome . J Heart Lung Transplant . 1996;15:100–105
  26. Brasch F , Muller KM . Classification of pulmonary alveolar proteinosis in newborns, infants, and children . Pathologe . 2004;25:299–309
  27. Shulenin S , et al.   ABCA3 gene mutations in newborns with fatal surfactant deficiency . N Engl J Med . 2004;350:1296–1303
  28. Tredano M , et al.   Mutation of SFTPC in infantile pulmonary alveolar proteinosis with or without fibrosing lung disease . Am J Med Genet . 2004;126A:18–26
  29. Majnemer A , et al.   Severe bronchopulmonary dysplasia increases risk for later neurological and motor sequelae in preterm survivors . Dev Med Child Neurol . 2000;42:53–60
  30. Serrano-Ikkos E , et al.   Incomplete adherence after pediatric heart and heart-lung transplantation . J Heart Lung Transplant . 1998;17:1177–1183
  31. Trulock EP , Edwards LB , Taylor DO , Boucek MM , Keck BM , Hertz MI . Registry of the International Society for Heart and Lung Transplantation (twenty-second official adult lung and heart-lung transplant report—2005) . J Heart Lung Transplant . 2005;24:956–967
  32. Shane E , et al.   Bone loss and fracture after lung transplantation . Transplantation . 1999;68:220–227
  33. Ujhelyi R , et al.   Bone mineral density and bone acquisition in children and young adults with cystic fibrosis (a follow-up study) . J Pediatr Gastroenterol Nutr . 2004;38:401–406
  34. Madill J , et al.   Nutritional assessment of the lung transplant patient (body mass index as a predictor of 90-day mortality following transplantation) . J Heart Lung Transplant . 2001;20:288–296
  35. Snell GI , et al.   Body mass index as a predictor of survival in adults with cystic fibrosis referred for lung transplantation . J Heart Lung Transplant . 1998;17:1097–1103
  36. Aris RM , et al.   Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type . Am J Respir Crit Care Med . 2001;164:2102–2106
  37. De Soyza A , Corris PA . Lung transplantation and the Burkholderia cepacia complex . J Heart Lung Transplant . 2003;22:954–958
  38. Serrano-Ikkos E , Lask B , Whitehead B , Eisler I . Incomplete adherence after pediatric heart and heart-lung transplantation . J Heart Lung Transplant . 1998;17:1177–1183
  39. Sredl D , Werner T , Springhart D , et al.   An evidence-based pilot study exploring relationships between psychologic and physiologic factors in post-lung-transplant adolescents with cystic fibrosis . J Ped Nurs . 2003;18:216–220
  40. Sundaresan S , Semenkovich J , Ochoa L , et al.   Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs . J Thorac Cardiovasc Surg . 1995;109:1075–1079
  41. Huddleston CB , Mendeloff EN . Heart and lung preservation for transplantation . J Card Surg . 2000;15:108–121
  42. King RC , Binns OAR , Rodriguz F , et al.   Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation . Ann Thorac Surg . 2000;69:1681–1685
  43. Date H , Triantafillou AN , Trulock EP , et al.   Inhaled nitric oxide reduces human lung allograft dysfunction . J Thorac Cardiovasc Surg . 1996;111:913–919
  44. Matsuzaki Y , Waddell TK , Puskas JD , et al.   Amelioration of post-ischemic lung reperfusion injury by prostaglandin E1 . Am Rev Respir Dis . 1993;148:882–889
  45. Metras D , et al.   Lung infections in pediatric lung transplantation (experience in 49 cases) . Eur J Cardiothorac Surg . 1999;15:490–494
  46. Apalsch AM , et al.   Parainfluenza and influenza virus infections in pediatric organ transplant recipients . Clin Infect Dis . 1995;20:394–399
  47. Bridges ND , et al.   Adenovirus infection in the lung results in graft failure after lung transplantation . J Thorac Cardiovasc Surg . 1998;116:617–623
  48. Sheridan PH , Cheriyan A , Doud J , et al.   Incidence of phrenic neuropathy after isolated lung transplantation . J Heart Lung Transplant . 1995;14:684–691
  49. Huddleston CB , Sweet SC , Mallory GB , et al.   Lung transplantation in very young infants . J Thorac Cardiovasc Surg . 1999;118:796–804
  50. Gandhi SK , Bromberg BI , Schuessler RB , et al.   Left sided atrial flutter–characterization of a novel complication of pediatric lung transplantation in an acute canine model . J Thorac Cardiovasc Surg . 1996;112:992–1001
  51. Sundaresan S , Trulock EP , Mohanakumar T , Cooper JD , Patterson GA . Prevalence and outcome of bronchiolitis syndrome after lung transplantation . Ann Thorac Surg . 1995;60:1341–1346
  52. Ganne V , Siddiqi N , Kamaplath B , et al.   Humanized anti-CD20 monoclonal antibody (rituximab) treatment for post-transplant lymphoproliferative disorder . Clin Transplant . 2003;17:417–422
  53. Swinnen LJ , Mullen GM , Carr TJ , Costanzo MR , Fisher RI . Aggressive treatment for postcardiac transplant lymphoproliferation . Blood . 1995;86:3333–3340
  54. Hislop AA , Odom NJ , McGregor CGA , Haworth SG . Growth potential of the immature transplanted lung (an experimental study) . J Thorac Cardiovasc Surg . 1990;100:360–370
  55. Kern JA, Tribble CG, Flanagan TL, Chan BBK, Scott WW, Cassada DC, et al. Growth potential of porcine reduced-size mature pulmonary lobar transplants . J Thorac Cardiovasc Surg . 1992;104:1329–1332
  56. Cohen AH , Mallory GB , Ross K , et al.   Growth of lungs after transplantation in infants and in children younger than 3 years of age . Am J Resp Crit Care Med . 1999;159:1747–1751

PII: S1055-8586(06)00030-8

doi: 10.1053/j.sempedsurg.2006.03.006

Seminars in Pediatric Surgery
Volume 15, Issue 3 , Pages 199-207 , August 2006

Article Tools

* Image Usage & Resolution